APOTEX CORP.

Lobbying client · Florida · filed 2025 to 2026

Manufacturing

$4,310,000 Reported spend

26 Filings counted

4 Outside firms hired

10 Bills named

Spend is reported income plus in-house expenses across 26 filings. 1 further filing for this client was restated by a later amendment and is left out of every total here. The LDA keeps a separate client record for every registrant that files for a client, so this page adds up 5 records, one per registrant listed below. Records are combined when the client name matches once case, punctuation and endings such as Inc. or LLC are set aside; for a city, county or port the state has to match as well. These filings have also been reported as APOTEX CORPORATION, APOTEX, CORP.

Who filed for this client 5

APOTEX CORP. $3,360,000 In-house, the client's own filings · 7 filings
BALLARD PARTNERS $440,000 Outside firm · 4 filings
KOUNTOUPES DENHAM CARR & REID, LLC $350,000 Outside firm · 7 filings
GOVERNMENT COUNSEL, LLC $160,000 Outside firm · 7 filings
STEPTOE LLP $0 Outside firm · 1 filing

Spend per registrant: fees an outside firm reported, or the costs the client reported for lobbying in-house. The rows add up to the total above.

Bills named in these filings 10

S. 43
Skinny Labels, Big Savings Act

4 filings
H.R. 1483
Protecting Investors’ Personally Identifiable Information Act

2 filings
H.R. 6485
Skinny Labels, Big Savings Act

2 filings
S. 1302
Increasing Transparency in Generic Drug Applications Act

2 filings
H.R. 3269
ETHIC Act

1 filing
H.R. 5526
Biosimilar Red Tape Elimination Act

1 filing
S. 1954
Biosimilar Red Tape Elimination Act

1 filing
S. 2276
ETHIC Act

1 filing
S. 2296
National Defense Authorization Act for Fiscal Year 2026

1 filing
S.J. Res. 37
A joint resolution terminating the national emergency declared to impose duties on articles imported from Can…

1 filing

Reported by year 2 years

2026 $1,910,000 10 filings
2025 $2,400,000 16 filings

Issues lobbied 5

The count is how many filings named that issue area. A filing reports one lump figure covering every issue on it, so the money above cannot be split between them.

Agencies and chambers lobbied 10

SENATE 18
HOUSE OF REPRESENTATIVES 15
Natl Economic Council (NEC) 6
U.S. Trade Representative (USTR) 6
Office of Management & Budget (OMB) 4
White House Office 4
Commerce, Dept of (DOC) 2
Executive Office of the President (EOP) 2
Natl Security Council (NSC) 2
Bureau of Industry and Security (BIS) 1

Recent filings 27 total

Registration

STEPTOE LLP

4th Quarter 2026 (Oct 1 - Dec 31) · posted Nov 4, 2026

View → Q3 report

APOTEX CORP.

3rd Quarter 2026 (July 1 - Sep 30) · House · Senate · $220,000 expenses · posted Oct 19, 2026

View → Q3 report

GOVERNMENT COUNSEL, LLC

3rd Quarter 2026 (July 1 - Sep 30) · $30,000 income · posted Oct 8, 2026

View → Q3 report

KOUNTOUPES DENHAM CARR & REID, LLC

3rd Quarter 2026 (July 1 - Sep 30) · Senate · $50,000 income · posted Oct 6, 2026

View → Q2 report

GOVERNMENT COUNSEL, LLC

2nd Quarter 2026 (Apr 1 - June 30) · $30,000 income · posted Jul 20, 2026

View → Q2 report

APOTEX CORP.

2nd Quarter 2026 (Apr 1 - June 30) · House · Senate · $730,000 expenses · posted Jul 20, 2026

View → Q2 report

KOUNTOUPES DENHAM CARR & REID, LLC

2nd Quarter 2026 (Apr 1 - June 30) · Senate · $50,000 income · posted Jul 8, 2026

View → Q1 report

APOTEX CORP.

1st Quarter 2026 (Jan 1 - Mar 31) · House · Senate · $730,000 expenses · posted Apr 20, 2026

View → Q1 report

GOVERNMENT COUNSEL, LLC

1st Quarter 2026 (Jan 1 - Mar 31) · House · Senate · $20,000 income · posted Apr 17, 2026

View → Q1 report

KOUNTOUPES DENHAM CARR & REID, LLC

1st Quarter 2026 (Jan 1 - Mar 31) · Senate · $50,000 income · posted Apr 9, 2026

View → Q4 termination

BALLARD PARTNERS

4th Quarter 2025 (Oct 1 - Dec 31) · $80,000 income · posted Jan 19, 2026

View → Q4 report

GOVERNMENT COUNSEL, LLC

4th Quarter 2025 (Oct 1 - Dec 31) · House · Senate · $20,000 income · posted Jan 19, 2026

View → Q4 report

APOTEX CORP.

4th Quarter 2025 (Oct 1 - Dec 31) · House · Senate · $260,000 expenses · posted Jan 19, 2026

View → Q4 report

KOUNTOUPES DENHAM CARR & REID, LLC

4th Quarter 2025 (Oct 1 - Dec 31) · House · Senate · $50,000 income · posted Jan 14, 2026

View → Q3 report

APOTEX CORP.

3rd Quarter 2025 (July 1 - Sep 30) · House · Senate · $310,000 expenses · posted Oct 17, 2025

View → Q3 report

BALLARD PARTNERS

3rd Quarter 2025 (July 1 - Sep 30) · $120,000 income · posted Oct 14, 2025

View → Q3 report

KOUNTOUPES DENHAM CARR & REID, LLC

3rd Quarter 2025 (July 1 - Sep 30) · $50,000 income · posted Oct 9, 2025

View → Q3 report

GOVERNMENT COUNSEL, LLC

3rd Quarter 2025 (July 1 - Sep 30) · House · Senate · $20,000 income · posted Oct 2, 2025

View → Q2 report

APOTEX CORP.

2nd Quarter 2025 (Apr 1 - June 30) · House · Senate · $300,000 expenses · posted Jul 18, 2025

View → Q2 report

KOUNTOUPES DENHAM CARR & REID, LLC

2nd Quarter 2025 (Apr 1 - June 30) · House · Senate · $50,000 income · posted Jul 17, 2025

View →

Showing the 20 most recent of 27 filings. Search the explorer for "APOTEX CORP.".

Foreign entities disclosed 1

APOTEX INC. Canada named on 2 filings · highest disclosed ownership 0% · largest disclosed contribution $0

Section 7 of the LD-2: a foreign company or government that owns part of the client, pays toward the lobbying, or benefits from it. Figures are the highest single disclosure across these filings, not a sum: the same stake is re-disclosed each quarter.

Keep going

Filings through November 4, 2026, the newest posted date on this record. Source: federal Lobbying Disclosure Act filings, synced daily. Money is self-reported by the filer and often rounded. Lobbying is legal, disclosed activity.